Literature DB >> 3497751

Pharmacologic effects on the expression of class II histocompatibility antigen in experimental endotoxin-induced uveitis.

M K Kim, C C Chan, R B Nussenblatt, A G Palestine.   

Abstract

Systemic dexamethasone, cyclosporine A, colchicine, indomethacin, and cobra venom factor were administered to Lewis rats that were then challenged with 100 micrograms of Salmonella typhimurium endotoxin. The effects of these five pharmacologic agents in endotoxin-induced uveitis were studied by analyzing their effects on ocular inflammation and on the expression of class II antigen of the major histocompatibility complex (MHC) on the epithelium of the ciliary body and iris. All the agents used in our study exhibited anti-inflammatory effects but only dexamethasone was able to inhibit significantly the expression of Ia antigen on the uveal epithelium. This demonstrates a dissociation between the inflammation and class II antigen expression and supports our previous data that class II antigen presentation may precede the inflammatory infiltrates. The alteration of ocular inflammation and especially the variation of Ia antigen expression in the uveal tissue may provide insight into the mechanism of action and the success of different pharmacologic agents used in the treatment of uveitis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3497751     DOI: 10.1016/0090-1229(87)90113-9

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  5 in total

1.  Henoch-Schonlein purpura with keratitis and granulomatous anterior uveitis.

Authors:  M M K Muqit; M J Gallagher; M Gavin; F Roberts; A G Jardine
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

Review 2.  Immunoregulation of uveitis.

Authors:  R B Nussenblatt
Journal:  Int Ophthalmol       Date:  1990-01       Impact factor: 2.031

Review 3.  Immunopathology of uveitis.

Authors:  C C Chan; Q Li
Journal:  Br J Ophthalmol       Date:  1998-01       Impact factor: 4.638

4.  The influence of penetrating keratoplasty and cyclosporin A therapy on MHC class II (Ia)-positive cells in the rat iris and choroid.

Authors:  S E Coupland; L Krause; F Hoffmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-02       Impact factor: 3.117

Review 5.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.